What are the mechanisms that cause hypoalbuminemia in sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanisms of Hypoalbuminemia in Sepsis

Hypoalbuminemia in sepsis results from multiple simultaneous mechanisms: increased transcapillary escape of albumin into the extravascular space (especially in early sepsis), hemodilution from fluid resuscitation and increased plasma volume, suppressed hepatic albumin synthesis via NF-κB activation by lipopolysaccharide, and increased peripheral catabolism of albumin in tissues. 1, 2, 3

Primary Pathophysiologic Mechanisms

Increased Capillary Permeability and Albumin Redistribution

  • Accelerated transcapillary escape is the dominant mechanism during early sepsis (first 24-48 hours), with albumin transcapillary escape rate (TER) significantly elevated on days 1 and 6 after infection, though absolute efflux increases only during day 1. 1

  • Once albumin leaks into the extravascular space, it becomes retained in tissues where it undergoes catabolism, contributing to net protein loss from the body. 1, 2

  • The increased vascular permeability in sepsis allows albumin (a 60 kDa molecule) to cross the endothelial barrier more readily, reducing the oncotic pressure gradient and promoting further fluid shifts. 4

  • Importantly, albumin supplementation does not reverse this increased permeability—even when serum albumin is nearly doubled (from 10.3 to 18.5 g/L), the transcapillary escape rate remains unchanged at approximately 6.7%/hour. 5

Hemodilution and Volume Expansion

  • Increased plasma volume from fluid resuscitation and the systemic inflammatory response directly dilutes serum albumin concentration, accounting for a substantial portion of the observed hypoalbuminemia. 1

  • The increased cardiac output and renal blood flow characteristic of early sepsis (in absence of acute kidney failure) further expands the intravascular volume. 4

Suppressed Hepatic Synthesis

  • Lipopolysaccharide (LPS) directly suppresses albumin gene expression in hepatocytes by activating the NF-κB signaling pathway, representing a transcriptional mechanism of reduced albumin production. 3

  • This suppression occurs despite the liver's attempt to compensate—paradoxically, some septic patients demonstrate supranormal albumin synthetic rates (mean 215 mg/kg/day, range 21-447 mg/kg/day) even while maintaining severely depressed serum levels (mean 1.98 g/dL). 2

  • The lack of correlation between serum albumin levels and hepatic synthetic capacity indicates that serum albumin does not reliably reflect hepatic function or visceral protein status in critically ill patients. 2

Increased Peripheral Catabolism

  • Extravascular protein redistribution and increased peripheral catabolism are major factors responsible for hypoalbuminemia, particularly as sepsis progresses beyond the acute phase. 2

  • After the initial phase of increased transcapillary escape, other catabolic mechanisms predominate since albumin efflux returns to normal by day 10 while hypoalbuminemia persists. 1

Clinical Implications for Beta-Lactam Pharmacokinetics

  • Hypoalbuminemia increases the free fraction of highly protein-bound beta-lactams (cefazolin, ceftriaxone, ertapenem), leading to increased volume of distribution, enhanced tissue penetration, and accelerated elimination through glomerular filtration. 4

  • This pharmacokinetic alteration necessitates measuring albumin or plasma proteins at treatment onset and during therapeutic drug monitoring to guide antibiotic dosing in septic patients. 4

Temporal Evolution

  • Early sepsis (days 1-6): Increased transcapillary escape and hemodilution dominate. 1

  • Late sepsis (day 10 onward): Peripheral catabolism and suppressed synthesis become more important as transcapillary escape rates normalize. 1

  • Throughout all phases, net albumin loss from the body continues, reflecting the combined impact of all mechanisms. 1

References

Research

Increased albumin plasma efflux contributes to hypoalbuminemia only during early phase of sepsis in rats.

American journal of physiology. Regulatory, integrative and comparative physiology, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effects of albumin supplementation on microvascular permeability in septic patients.

Journal of applied physiology (Bethesda, Md. : 1985), 2002

Related Questions

At what serum albumin level should hypoalbuminemia be corrected in a patient with sepsis?
What is the recommended dose of albumin for a patient with third spacing and potentially severe hypoalbuminemia, considering their medical history and risk of volume overload?
What is the recommended dose of albumin (human albumin) for a patient undergoing a ponction (percutaneous procedure)?
What is the role of albumin in treating third spacing (edema)?
What are the indications and dosages for albumin (human albumin) administration in various medical conditions?
For a 45‑year‑old woman at 35 weeks gestation undergoing scheduled cesarean delivery with BMI 31 (obesity) and no other venous thromboembolism risk factors, what venous thromboembolism prophylaxis (pharmacologic and mechanical) is indicated?
What oral antibiotic is recommended for an adult with uncomplicated cystitis that is resistant to nitrofurantoin (Macrobid) and ciprofloxacin?
What are the approved and off‑label uses, dosing regimens, contraindications, and alternative therapies for bupropion (including Zyban)?
Can angiotensin II receptor blockers (ARBs) cause hyperkalemia, especially in patients with impaired renal function, diabetes mellitus, or who are taking other potassium‑sparing agents?
For an adult with acute coronary syndrome undergoing percutaneous coronary intervention and no contraindications, which P2Y12 inhibitor—ticagrelor, prasugrel, or clopidogrel—is the most appropriate choice?
What additional systemic evaluation is indicated for a 20‑year‑old woman with an apparent central retinal vein occlusion causing acute unilateral blindness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.